Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report
NCT05559229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2022-09-29
Summary
Alpha-fetoprotein (AFP) can become elevated in hepatocellular carcinoma (HCC), yolk sac tumors and other malignant tumors of various organs. Herein, the investigator present a case of AFP-producing gallbladder carcinoma with signet ring cells successfully treated with laparoscopic whole-layer cholecystectomy.
Conditions
- Gallbladder Cancer
Interventions
- PROCEDURE
-
laparoscopic whole-layer cholecystectomy
laparoscopic whole-layer cholecystectomy.
Sponsors & Collaborators
-
junya mita
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-15
- Primary Completion
- 2022-06-25
- Completion
- 2022-09-18
Countries
- Japan
Study Locations
More Related Trials
-
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC
NCT02535117 ·Status: UNKNOWN ·Phase: PHASE4
-
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
NCT00373347 ·Status: COMPLETED
-
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
NCT04414956 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer
NCT07145385 ·Status: NOT_YET_RECRUITING
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Laparoscope Anatomical and Aon-anatomical Hepatectomy
NCT02009176 ·Status: UNKNOWN ·Phase: NA
-
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Value of AFP-L3 and PIVKA-II in HCC
NCT03460080 ·Status: UNKNOWN
-
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
NCT00154531 ·Status: UNKNOWN
-
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease
NCT03307408 ·Status: COMPLETED
-
Fluorescent-labeled IgG for Liver Tumor Detection
NCT05394246 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy
NCT07182136 ·Status: COMPLETED
-
Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)
NCT01846949 ·Status: UNKNOWN
-
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335 ·Status: RECRUITING
-
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
NCT03156582 ·Status: COMPLETED
-
Metabolic Dysfunction-Associated Fatty Liver Disease Impairs Intraoperative Indocyanine Green Fluorescence Cholangiography Quality: Development and Validation of a Predictive Model
NCT07297225 ·Status: COMPLETED
-
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation
NCT02046356 ·Status: UNKNOWN
-
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
NCT06331260 ·Status: NOT_YET_RECRUITING
-
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779 ·Status: UNKNOWN
-
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma
NCT02541149 ·Status: COMPLETED
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
NCT05756699 ·Status: ACTIVE_NOT_RECRUITING
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Pancreatic Juice Diagnosis From Duodenum
NCT01699698 ·Status: COMPLETED ·Phase: NA
-
Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI
NCT04559451 ·Status: UNKNOWN